Significance of Combined Emphysema in Idiopathic Pulmonary Fibrosis and Serum Surfactant Protein-D as a Prognostic Factor
Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2017, Vol 4, Issue 2
Abstract
Background and Objectives Idiopathic pulmonary fibrosis (IPF) is a chronic disease of unknown aetiology and is often associated with a syndrome called combined pulmonary fibrosis and emphysema (CPFE). This study aimed to identify practical predictors of prognosis in IPF patients associated with CPFE. Subjects and Methods We retrospectively studied 72 patients with IPF and evaluated the threshold of emphysematous area affecting prognosis on high-resolution computed tomography (HRCT) scans. As predictor candidates, various pulmonary function tests (PFTs) and biomarkers, e.g. surfactant protein (SP)-A and SP-D, were assessed. Results The survival rate of the CPFE group, defined as having an emphysematous area greater than 25% on HRCT, was significantly worse than that of the non-CPFE group, despite no significant difference in fibrosis scores. An annual percent decline of diffusing capacity of the lung for carbon monoxide (% DLCO) of more than 5% was a significant prognostic factor in the CPFE group. High concentration of serum SP-D was a significant prognostic factor in both the CPFE and non-CPFE groups. However, cut-off levels in the CPFE group were lower than those in the non-CPFE group. Conclusions We demonstrated worse prognosis in IPF associated with CPFE syndrome compared to the other subset of IPF, and showed that % DLCO and SP-D are useful predictors of poor prognosis.
Authors and Affiliations
Masanori Shiratori
Keywords
Related Articles
- EP ID EP546159
- DOI 10.17140/PRRMOJ-4-135
- Views 199
- Downloads 0
Explosive Pleurisy Related to Group a Streptococcal Infection: A Case Report and Literature Review
Group A Streptococcus (GAS) can cause invasive infections, such as pneumonia. It is rarely associated with a rapidly progressing exudative pleural effusion termed “explosive pleurisy”, leading to significant morbidity an...
Biomarkers for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD): What is the Role of microRNAs?
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous respiratory disease characterized by a progressive, not fully reversible airflow limitation associated with an abnormal inflammatory response of the lungs t...
Pleural Diseases in Pregnancy: Aetiology and Management
Pleural diseases in pregnancy can cause considerable maternal and fetal morbidity and mortality. Some like pleural effusions may be small and pose like danger or massive causing significant respiratory compromise. Others...
Microarray Analysis Identifies Pathways in Progression of Early Stage Lung Adenocarcinoma: The Importance of Focal Adhesion and ECM-Receptor Interactions
Recurrence after lung cancer surgery is high, even among Non-Small Cell Lung Cancer (NSCLC) adenocarcinoma patients diagnosed early as Stage I, where there has been no spread to lymph nodes. Understanding the biological...
Hydrogen Sulfide in Airway Diseases
Hydrogen Sulfide (H2S) is a colorless, water-soluble gas with the odor of rotten eggs. H2S can be produced via non-enzymatic pathways, but is mainly synthesized from L-cysteine as the substrate by Cystathionine-γ-lyase (...